Zheng Liu | Arts and Humanities | Research Excellence Award

Assoc. Prof. Dr. Zheng Liu | Arts and Humanities | Research Excellence Award 

Associate Professor at Shanghai Jiao Tong University | China

Assoc. Prof. Dr. Zheng Liu is an accomplished scholar whose work stands at the forefront of contemporary philosophical inquiry, particularly in the areas of phenomenology, philosophy of technology, and comparative philosophy. With 7 publications, 2,530 reads, and 10 citations, his research demonstrates a growing international influence and a strong commitment to advancing interdisciplinary dialogue within the Arts and Humanities. Educated in philosophy at Soochow University, where he completed his master’s degree, Assoc. Prof. Dr. Zheng Liu further deepened his theoretical foundation by pursuing doctoral studies in the Department of Philosophy at Peking University, earning his Ph.D.His academic development includes a significant period as a visiting scholar at the University of Bergen in Norway, supported by the Research Council of Norway, which enriched his comparative perspectives and expanded his engagement with global scholarly communities. Professionally, Assoc. Prof. Dr. Zheng Liu has built a strong trajectory at the School of History and Culture of Science at Shanghai Jiao Tong University, serving first as an assistant professor and later advancing to his current role as associate professor, where he contributes to both teaching and research in areas that bridge philosophical traditions and contemporary technological challenges. His research interests encompass the phenomenological philosophy of technology, Merleau Ponty studies, cross-cultural philosophical analysis, ethical implications of emerging technologies, datafied embodiment, and human technology relations within both Western and Eastern intellectual traditions. Across his published works, he critically investigates concepts such as technological mediation, body network theory, digital enhancement, Indra’s Net metaphysics, the Internet of Bodies, and the shifting nature of embodied experience in technologically mediated environments. By integrating phenomenological frameworks with insights from Chinese philosophical thought, he offers innovative perspectives on issues such as moral agency, digital ethics, ecological embodiment, and the transformative impact of data driven technologies on human life. Assoc. Prof. Dr. Zheng Liu’s scholarship contributes meaningfully to global discussions on the ethical, social, and philosophical dimensions of technology, and his work continues to shape emerging debates in modern humanities research. In conclusion, Assoc. Prof. Dr. Zheng Liu stands as a dedicated and forward-thinking researcher whose contributions enrich philosophical understanding while offering vital insights into the rapidly evolving relationship between humans, culture, and technology.

Profile: Orcid | Researchgate

Featured Publications:

Liu, Z. (2025). When Merleau-Ponty encounters Fazang: Comparing Merleau-Pontian body-network with Fazang’s interpretation of Indra’s Net for a critical techno-ethics. Religions, 16(11), 1425.

Liu, Z. (2025). Toward datafied human enhancement: Concept, functional classifications and ethical issues. Filosofija. Sociologija, 36(1), 85–93.

Liu, Z. (2024). Toward datafied human enhancement: Concept, functional classifications and ethical issues (Preprint).

Liu, Z. (2023). Internet of Bodies, datafied embodiment and our quantified religious future. HTS Teologiese Studies / Theological Studies, 79(1), Article 8398.

Liu, Z. (2022). Flesh, vital energy and illness: A comparative phenomenological study of human–nature relations inspired by the contexts of Later Merleau-Ponty and the Zhuangzi. Religions, 13(7), 637.

Liu, Z. (2022). Technological mediation theory and the moral suspension problem. Human Studies, 46, 375–388.

Liu, Z. (2020).On the technological issues in Merleau-Ponty’s phenomenology of the body. Universitas Monthly Review of Philosophy and Culture, 47(10), 161–176.

Jianfeng Wang | Chemistry | Research Excellence Award

Dr. Jianfeng Wang | Chemistry | Research Excellence Award 

Senior Engineer at Beijing Academy of Science and Technology | China

Dr.Jianfeng Wang is a distinguished researcher and Senior Engineer known for his significant contributions to analytical chemistry and applied scientific innovation, particularly at the Institute of Analysis and Testing, Beijing Academy of Science and Technology. With a solid academic foundation in chemistry and analytical sciences, Dr.Jianfeng Wang has built a strong professional trajectory focused on developing advanced methods and technologies that strengthen modern analytical platforms. Over the course of his career, he has produced a substantial body of scholarly work, including 20 academic documents that have collectively received 803 citations by 760 documents, supporting an h-index of 12 and demonstrating his sustained impact on the scientific community. Dr.Jianfeng Wang’s professional experience includes participation and leadership in several national-level research initiatives aimed at strengthening national analytical and technological capabilities, including involvement in major National Key R&D Programs addressing quality infrastructure, science and technology cooperation, and large-scale cross-institutional research development. His research interests span non-targeted analysis, metabolomics, and the development of intelligent sample pretreatment equipment, reflecting a forward-looking vision for laboratory automation, precision enhancement, and accelerating data-driven insights in chemical analysis. Jianfeng Wang has also contributed heavily to scientific and industrial advancement through the publication of 30+ research papers, the development of patented technologies, book authorship, and participation in the creation of national and group standards, thereby influencing both theoretical understanding and practical implementation of analytical techniques across the field. His experience at the Beijing Academy of Science and Technology has enabled him to collaborate with multidisciplinary teams, integrate emerging scientific methodologies, and contribute to the strengthening of research infrastructure within the wider scientific community. Through innovative project execution, academic output, and technical leadership, Jianfeng Wang continues to support progress in analytical chemistry, materials characterization, and advanced testing systems that benefit a broad array of scientific and industrial applications. His ongoing work demonstrates a commitment to improving analytical precision, methodological robustness, and instrumental efficiency, making him a respected figure in contemporary chemical research. In conclusion, Jianfeng Wang’s achievements, publication record, contributions to national-level programs, and sustained scholarly influence reinforce his reputation as a leading expert committed to advancing the frontiers of analytical science and technological innovation.

Profile: Scopus

Featured Publications:

Wang, J., et al. (2026). Fixed-bed catalytic antibiotics detoxification through singlet oxygen-mediated nonradical oxidation: Mechanisms and long-term performance. Water Research.

Wang, J., et al. (2025). Orbital hybridization-driven singlet oxygen generation in piezo-photocatalytic self-fenton system: Synergistic band engineering and spin-state modulation for sustainable water remediation. Applied Catalysis B: Environmental.

Shazid Md.Sharker | Toxicology and Pharmaceutical Science | Collaborative Research Excellence Award

Assoc. Prof. Dr. Shazid Md.Sharker | Toxicology and Pharmaceutical Science | Collaborative Research Excellence Award 

Associate Professor at North South University | Bangladesh 

Assoc. Prof. Dr. Shazid Md. Sharker is an accomplished academic and researcher in the field of pharmaceutical sciences, widely recognized for his contributions to nanomedicine, drug delivery, and cancer theranostics. With a strong academic foundation built through advanced degrees in pharmaceutical sciences and research experiences at internationally respected institutions, he has developed expertise in the synthesis and application of nanocarriers, fluorescence nanoparticles, biomaterials, and photothermal systems for targeted therapeutic and diagnostic applications. His research portfolio demonstrates a sustained commitment to advancing next-generation drug delivery approaches using liposomes, PLGA nanoparticles, gelatin-based systems, and carbon dots, alongside innovative strategies involving NIR-light activation, microneedle technology, polymer conjugation, and real-time imaging platforms. Assoc. Prof. Dr. Shazid Md. Sharker has produced impactful research within high-visibility international journals and conferences, earning 1,801 citations by 1,470 documents, 47 scientific publications, and an h-index of 22, reflecting significant scholarly influence and peer recognition. His experience extends to leading and collaborating on multidisciplinary research projects funded by national and institutional bodies, contributing extensively to knowledge advancement in toxicology, pharmaceutical product development, biomedical engineering, and cancer therapy design. He is also engaged in academic journal activities as a reviewer and guest editor for multiple international publications, supporting research integrity and strengthening scientific communication within the global community. In addition to his academic research, he has applied his expertise to teaching advanced pharmaceutical science subjects, training students and emerging scholars in analytical methods, formulation technologies, and experimental biomedical design. His scientific explorations focus on the interface between engineered materials and biological systems, striving to develop precise, responsive, and personalized therapeutic technologies capable of improving patient outcomes in oncology and other clinical areas. Through continuous research productivity, interdisciplinary collaboration, and contributions to academic development, Assoc. Prof. Dr. Shazid Md. Sharker has established a strong professional reputation as a leading contributor in pharmaceutical nanotechnology and therapeutic innovation. His achievements demonstrate long-term dedication to expanding scientific understanding, fostering effective healthcare solutions, and supporting the next generation of pharmaceutical researchers and practitioners.

Profile: Scopus | Orcid 

Featured Publications: 

Sharker, S. M. (2025). Stealth Drug Delivery of Mouse Serum Albumin-Coated Paclitaxel-Loaded Gelatin Nanoparticles for Targeted Cancer Therapy in Mice. Nano Select.

Sharker, S. M. (2024). Skin Cancer Treatment with Subcutaneous Delivery of Doxorubicin-Loaded Gelatin Nanoparticles and NIR Activation. ACS Applied Bio Materials.

Sharker, S. M. (2024). Trackable Liposomes for In Vivo Delivery Tracing toward Personalized Medicine Care under NIR Light on Skin Tumor. ACS Applied Bio Materials.

Sharker, S. M. (2024). Synergistic Effect of ROS-Generating Polydopamine on Drug-Induced Bone Tissue Regeneration. Nanoscale.

Sharker, S. M. (2023). NIR-Light-Triggered Delivery of Doxorubicin-Loaded PLGA Nanoparticles for Synergistic Cancer Therapy on Tumor-Bearing Mice. Materials Advances.

Sharker, S. M. (2023). Interaction of Microwave and Nanomaterials for Thermoresponsive Drug Delivery and Hyperthermal Cancer Therapy. Inorganic Chemistry Communications.

Sharker, S. M. (2023). Nanostructured Chitosan-Polyphenolic Patch for Remote NIR-Controlled Dermal Drug Delivery. International Journal of Biological Macromolecules.

Sharker, S. M. (2022). Emerging Biomedical Applications of Carbon Dot and Polymer Composite Materials. Applied Sciences.

Sharker, S. M. (2022). QbD Approach Toward Design and Optimization of Nano-Delivery Systems. Polymers.

Sharker, S. M. (2022). Chronic Wound-Dressing Patch for pH-Responsive Antibacterial Therapy. Materials Today Communications.

Sharker, S. M. (2021). Remote Temperature-Responsive Parafilm Dermal Patch for On-Demand Drug Delivery. Micromachines.

Sharker, S. M. (2021). Nanoscale Carbon-Polymer Dots for Theranostics and Biomedical Exploration. Journal of Nanotheranostics.

Sharker, S. M. (2021). Targeting Cancer Cells with Nanotherapeutics and Nanodiagnostics. Seminars in Cancer Biology.

Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award

Dr. Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award 

Researcher at BioFront | South Korea

Dr. Sun Jong Kim is a highly accomplished biotechnology and life sciences professional whose career reflects sustained contributions to in vitro diagnostics, stem cell science, biomolecular research, and translational biomedical innovation. Equipped with a strong academic foundation including bachelor’s, master’s, and doctoral studies in life sciences, Dr. Sun Jong Kim has developed deep expertise in cellular biology, developmental biology, and molecular mechanisms of pluripotency. His professional journey includes senior research and leadership roles across multiple biomedical organizations, where he has guided R&D programs involving the establishment and maintenance of pluripotent stem cell lines, large-scale microalgae production systems, medical device development, and regulatory preparation for diagnostic technologies. He has contributed to the development of human embryonic stem cell resources, in vitro differentiation platforms, and advanced diagnostic systems applied to areas such as oncology, COVID-19 rapid testing, and point-of-care technologies. His industrial leadership also includes oversight of product development pipelines, quality assurance systems, and multidisciplinary research operations, demonstrating an ability to translate scientific results into usable biomedical solutions that directly support clinical and research infrastructures. His research outputs include numerous scientific publications, national and international presentations, and patents in areas such as stem cell culturing techniques, photobioreactors, and biomaterial-based innovations. The measurable impact of his scholarly contribution is represented by 24 citations by 24 documents, 2 indexed documents, and an h-index of 2, reflecting ongoing engagement and recognition within the scientific community. Dr. Sun Jong Kim’s research interests encompass stem cell biology, human cell culture systems, the regulation of self-renewal and differentiation pathways, bioprocess design, clinical diagnostics, and biotechnology commercialization. His work has been supported by significant research grants and has contributed to advancements in both academic discovery and applied biomedical engineering. In addition to laboratory research, he has played a crucial role in the development, certification, and evaluation of diagnostic medical devices aligned with international regulatory standards and real-world clinical needs. Through his ongoing work at Biofront and other institutions, Dr. Sun Jong Kim continues to drive innovation in science and technology, contributing to advancements that support more accurate diagnostics, greater understanding of biological systems, and the modernization of biomedical tools used in healthcare and life science research.

Profile: Scopus

Featured Publications:

Kim, S. J.,(1999). Isolation of developmentally regulated novel genes based on sequence identity and gene expression patterns. Molecules and Cells, 9, 207–218.

Kim, S. J.,(2001). Ovarian expression of melatonin Mel(1) receptor mRNA during mouse development. Molecular Reproduction and Development, 59, 126–132.

Kim, S. J.,(2003). Isolation and culture of human embryonic stem-like cells from abnormal blastocysts. Korean Journal of Fertility and Sterility, 30, 293–301.

Kim, S. J.,(2003). Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biology of Reproduction, 69, 2007–2014.

Kim, S. J.,(2004). Establishment of embryonic germ cells from cultured human primordial germ cells and their differentiation into neuronal cells. Molecules and Cells, 17, 309–315.

Kim, S. J.,(2004). Recent advances in human embryonic stem cell research. Journal of the Korean Medical Association, 918–925.

Kim, S. J.,(2004). Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. Stem Cells, 22, 950–961.

Kim, S. J.,(2004). Available human feeder cells for the maintenance of human embryonic stem cells. Reproduction, 128, 727–735.

Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Dr. Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Assistant Professor at Gaziantep University | Turkey

Dr. Serap Özdemir is a dedicated and forward-thinking academic whose contributions to nursing and health professions reflect a continuous commitment to advancing evidence-based pediatric and neonatal care. With a strong educational foundation culminating in doctoral-level training in child health and disease nursing, she has built a research portfolio focused on enhancing clinical outcomes for newborns, preterm infants, and children within diverse healthcare settings. Her professional experience includes teaching, academic leadership, and active involvement in multidisciplinary research collaborations that integrate nursing expertise with emerging scientific and technological innovations. Over the course of her academic career, nominee Dr. Serap Özdemir has developed a growing publication record consisting of 16 scholarly documents that have collectively earned 44 citations by 43 external publications, contributing to an h-index of 3 and demonstrating measurable influence within her field. Her research interests encompass neonatal intensive care, developmental health, the improvement of comfort and stress parameters in early infancy, and the application of modern data-driven tools such as artificial intelligence to clinical assessment and decision-making. She has taken part in multiple randomized controlled studies and instrument development projects designed to enhance the measurement of nursing performance, care quality, and professional competency in pediatric nursing environments. Her scientific output extends to peer-reviewed journals indexed in major research databases, as well as contributions to academic books and professional texts that support the dissemination of current best practices to nursing practitioners and students. Additionally, her work reflects a commitment to international engagement through collaborations, conference participation, and involvement in professional associations supporting knowledge exchange and healthcare improvement. Through these combined efforts, Dr. Serap Özdemir continues to shape contemporary thinking around neonatal and pediatric care, promoting research-driven nursing standards that emphasize compassionate, culturally sensitive, and scientifically validated interventions. She remains devoted to advancing healthcare delivery through continuous scholarship, the refinement of clinical methodologies, and the pursuit of innovative interdisciplinary solutions that support improved outcomes for vulnerable patient populations. Her ongoing work reinforces the essential role of nursing research in improving health systems globally and contributes meaningfully to the development of a more advanced, responsive, and patient-centered model of pediatric and neonatal care.

Profile: Scopus | Google Scholar

Featured Publicaations:

Özdemir, S., & Balcı, S. (2024). The effect of tub bathing on the skin and bilirubin levels of babies receiving tunnel and light-emitting diode phototherapies: A randomized controlled trial. Advances in Skin and Wound Care, 37(7), 1–9.

Özdemir, S., & Elmaoğlu, E. (2024). Psychometric properties of the pediatric ward nurses’ caring self-efficacy scale: A Turkish validity and reliability study. Journal of Pediatric Nursing, 75, 41–48.

Özdemir, S., & Küçük, F. (2023). The effect of the facilitated tucking after vaginal delivery on stress, comfort, and physiological parameters of late preterm infants: A randomized controlled trial. Iranian Journal of Neonatology, 14(4), 12–20.

Özdemir, S., & Sevinç, S. (2023). Correlation between cultural competence, xenophobia, and attitudes towards brain drain in nursing students. Nurse Education Today, 131, Article 105963.

Özdemir, S., & Elmaoğlu, E. (2023). Validity and reliability of the distracting ingenuity promotion scale in pediatric nurses. HUHEMFAD-JOHUFON, 10(3), 230–236.

Özdemir, S. (2022). Design of autonomous controlled integrated system for increasing comfort in newborns: Interdisciplinary collaboration between engineering and nursing studies. Dentistry & Medical Research, 8(2), 2–6.

Özdemir, S. (2022). Interdisciplinary collaboration between engineering and nursing: Baby crying analyzing using MATLAB graphical user interface. Biomed Biotechnology Research Journal, 6(3), 410–415.

Özdemir, S., & Yılmaz E. Ç. (2022). Interdisciplinary collaboration between engineering and nursing on baby crying analyzing and classification: A biotechnology study. Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, 1(2), 82–87.

Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award

Dr. Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award 

Rehabilitation Department Chair at Local Health Authority Italy

Dr. Cristina Maria Del Prete is a recognized professional in the field of Physical and Rehabilitation Medicine, known for her commitment to advancing innovative healthcare models, interdisciplinary rehabilitation practices, and measurable improvements in patient quality of life. She completed comprehensive medical education and specialized training in rehabilitation medicine, followed by multiple advanced executive and managerial qualifications focused on healthcare systems, organizational leadership, digital transformation, and strategic management. Her education laid a strong foundation for a career that has spanned clinical practice, healthcare administration, academic teaching, and national health policy participation. Over the years, she has held progressive leadership roles within major public healthcare structures, directing rehabilitation departments, coordinating multidisciplinary teams, and overseeing complex service networks involving hospital- and community-based rehabilitation centers. Her responsibilities have included workforce management, budget oversight, strengthening patient-care pathways, improving standards of disability support, and enhancing regional service delivery in alignment with evolving healthcare regulations. She has also actively contributed to national and regional scientific boards, steering committees, and professional societies focused on improving spasticity management, supporting patients with neurological conditions, addressing musculoskeletal pain, and advancing gender-inclusive perspectives within modern healthcare. Her research output reflects a strong blend of clinical relevance and academic rigor, focusing on post-stroke rehabilitation, botulinum toxin interventions in neuromotor disorders, gait analysis, scoliosis management, family coping mechanisms in the context of disability, and the psychological dynamics influencing care outcomes. Her published studies in international peer-reviewed journals demonstrate a dedication to evidence-based rehabilitation, resulting in 63 citations from 55 documents, 7 published scientific works, and an h-index of 4. She has also contributed extensively to academic progress through university teaching appointments across multiple medical programs, where she has trained students in foundational and advanced principles of rehabilitation medicine. International clinical training and professional development programs have further enhanced her expertise and broadened her exposure to advanced rehabilitative technologies, patient-centered methodologies, and global best practices. Throughout her career, she has remained consistently committed to improving health system performance, innovating care delivery frameworks, and conducting research that informs more efficient, equitable, and clinically effective rehabilitation services. Her professional journey reflects a continuous dedication to advancing healthcare quality, supporting both patients and practitioners, and strengthening the scientific foundations of modern rehabilitation.

Featured Publications:

Del Prete, C. M. (2025). Determinants of sibling relationships in the context of mental disorders. PLoS One.

Del Prete, C. M. (2025). Siblings of persons with disabilities: A systematic integrative review of the empirical literature. Clinical Child and Family Psychology Review.

Del Prete, C. M. (2023). Parentification, distress, and relationships with parents as factors shaping relationships in families with disability. Frontiers in Psychiatry.

Del Prete, C. M. (2022). An observational cross-sectional study of gender and disability as determinants of person-centered medicine in botulinum neurotoxin treatment of upper motoneuron syndrome. Toxins.

Del Prete, C. M. (2022). Brace treatment in adolescent idiopathic scoliosis: A rehabilitative point of view. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2021). Early botulinum toxin type A injection for post-stroke spasticity: A longitudinal cohort study. Toxins.

Del Prete, C. M. (2022). Efficacy of ultrasound-guided percutaneous lavage and biocompatible electrical neurostimulation in calcific rotator cuff tendinopathy. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2004). Conservative rehabilitative treatment of facial nerve injuries: A critical literature review. Europa Medicophysica.

Del Prete, C. M. (2002). Outcome research in adults with neurological disability. Europa Medicophysica.

Del Prete, C. M. (2001). Therapeutic water exercise in patients with hip arthroplasty. Europa Medicophysica.

Muhammad Inam Makki Khan | Business | Best Researcher Award

Mr. Muhammad Inam Makki Khan | Business | Best Researcher Award 

PhD scholar at Chang’an University | Pakistan

Mr. Muhammad Inam Makki Khan is a dedicated research professional in the field of logistics engineering, management, and business studies, recognized for contributing valuable insights to the evolving landscape of supply chain development and innovation. With a strong academic background culminating in doctoral studies in Logistics Engineering and Management, his education provides a solid theoretical and analytical foundation for exploring emerging challenges across global supply chains and business systems. Mr. Muhammad Inam Makki Khan has gained research experience through the exploration of supply chain performance, transportation systems, logistics technologies, sustainable business models, innovation management, and data-driven decision approaches in complex operating environments. His work emphasizes bridging the gap between theoretical advancements and practical solutions that organizations can adopt for improving resilience, efficiency, and competitiveness. His recent research demonstrates a growing emphasis on the integration of digital capabilities, fintech applications, big data analytics management capability, IoT solutions, and circular economy strategies, providing a comprehensive framework for understanding how modern organizations can adapt to disruptions, uncertainty, and volatile megaproject contexts. His contributions include empirical investigations supported by large-scale data models, offering validated and actionable insights for researchers, policymakers, and industry stakeholders. With academic metrics reflecting increasing scholarly reach Citations 88 87, h-index 3 3, and i10-index 1 1 his research impact continues to gain recognition, contributing to contemporary academic and industrial discourse. His studies commonly draw upon dynamic capabilities theory, sustainability principles, digital transformation literature, transportation planning, and strategic business adaptation, positioning his work within global research agendas aimed at modernizing infrastructure development and strengthening supply chains through technological integration. Beyond theoretical exploration, his published work highlights strategic approaches that organizations and government bodies may adopt to enhance operational performance while addressing environmental pressures and market uncertainties. His findings are especially relevant to high-risk, development-focused economic regions, where large-scale logistics systems require new frameworks for digital, responsive, and sustainable management. In conclusion, Mr. Muhammad Inam Makki Khan’s research trajectory reflects a growing commitment to shaping the future of sustainable supply chain development and contributing knowledge that supports innovation and long-term resilience in business systems worldwide.

Profile: Google Scholar

Featured Publications:

  • Khan, M. I. M. (2021). An analysis of human development index and economic growth: A case study of Pakistan. iRASD Journal of Economics, 3(3), 261–271.

  • Khan, M. I. M. (2024). Innovative technological solutions for environmental sustainability in Chinese engineering practices. Engineering, Technology & Applied Science Research, 14(2), 13648–13657.

  • Khan, M. I. M. (2021). Determinants of foreign direct investment in Pakistan. Meritorious Journal of Social Sciences and Management.

  • Khan, M. I. M. (2023). Factors affecting consumer brand loyalty in Pakistan. Bulletin of Business and Economics, 12(3), 855–860.

  • Khan, M. I. M. (2023). A novel CRYBB2 silent variant in autosomal dominant congenital cataracts (ADCC) in Pakistani families. Pakistan Journal of Medical Sciences, 39(5), 1399.

  • Khan, M. I. M. (2022). Governance as a stimulator for foreign direct investment in Pakistan: A non-linear ARDL approach. Journal of Contemporary Macroeconomic Issues, 3(2), 103–112.

  • Khan, M. I. M. (2024). Navigating innovation through ethical leadership: Insights from the dam industry. Proceedings of the 8th International Seminar on Education, Management and Social Sciences.

  • Khan, M. I. M. (2024). Comparative analysis of organizational governance, management practices, and learning environments in higher education institutions across different provinces. Remittances Review, 9(1), 1301–1325.

  • Khan, M. I. M. (2020). Soroprevalência de Toxoplasma gondii e alterações hematológicas associadas em pequenos ruminantes no sul do Punjab, Paquistão. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 72, 1698–1704.

Heuisoo Kim | Agricultural and Biological Sciences | Best Researcher Award

Prof. Heuisoo Kim | Agricultural and Biological Sciences | Best Researcher Award 

Biological Sciences at Pusan National University | South Korea

Prof. Heuisoo Kim is a prominent academic leader and influential researcher in the biological sciences, widely recognized for his significant contributions to genomics, molecular genetics, phylogeny, marine biology, and bioinformatics. He completed his Ph.D. in Genomics from Kyoto University, where he developed expertise in molecular analyses related to primate genetics, followed by an M.S. and B.S. in Biology from Pusan National University. His early postdoctoral work at leading institutes, including the Weizmann Institute of Science and the University of Oxford, provided a strong foundation for his long-standing academic career. Since joining Pusan National University as a professor, he has played key roles in advancing both research and academic leadership, including serving as Dean of the College of Natural Sciences and as President of the Genetics Society of Korea. His research portfolio is diverse and impactful, spanning the study of transposable elements, microRNA evolution, regulatory non-coding RNAs, endogenous retroviruses, host–pathogen interactions, and genome structure variations. He has published extensively on topics such as viral infection mechanisms in aquatic organisms, alternative splicing events induced by genomic integrations, enhancer functions of retroelement-derived microRNAs, and biomolecular dynamics associated with cancer progression. His work appears in high-impact journals across molecular biology, evolutionary genetics, aquaculture biotechnology, and immunology. With 4,659 citations by 3,884 documents, 299 published works, and an h-index of 36, his scholarly output reflects sustained excellence and global influence. Beyond research, he has contributed to national scientific development through roles such as Director of the Division of Life Sciences at the National Research Foundation of Korea and has been recognized with multiple prestigious national and international awards for outstanding research and academic service. His ongoing work continues to push the boundaries of molecular and genomic science, offering new insights into biological complexity and applied biotechnology. Prof. Heuisoo Kim’s career exemplifies dedication to advancing scientific knowledge, fostering collaborative research environments, and shaping the next generation of innovation in agricultural and biological sciences.

Profile: Scopus | Orcid

Featured Publications:

  • Kim H-S.,Hsa-miR-422a Originated from Short Interspersed Nuclear Element Increases ARID5B Expression by Collaborating with NF-E2. Molecules and Cells, 45(7), 465–478, 2022.

  • Kim H-S.,Z-DNA–Containing Long Terminal Repeats of Human Endogenous Retrovirus Families Provide Alternative Promoters for Human Functional Genes. Molecules and Cells, 45(8), 522–530, 2022.

  • Kim H-S.,Human Endogenous Retrovirus-H-Derived miR-4454 Inhibits the Expression of DNAJB4 and SASH1 in Non-Muscle-Invasive Bladder Cancer. Genes, 14, 1410–1422, 2023.

  • Kim H-S.,,Human Endogenous Retrovirus (HERV)-K env Gene Knockout Affects Tumorigenic Characteristics of nupr1 Gene in DLD-1 Colorectal Cancer Cells. International Journal of Molecular Sciences, 22(8), 3941, 2021.

  • Kim H-S.,A Study of Transposable Element–Associated Structural Variations (TASVs) Using a De Novo Assembled Korean Genome. Experimental & Molecular Medicine, 53, 615–630, 2021.

  • Kim H-S.,Disposable microRNA biosensors based on dual-role polymer-dispersed silver nanowires for diagnosis of viral hemorrhagic septicemia virus infection in olive flounder. Aquaculture, 580, 740287–780294, 2024.

  • Kim H-S.,Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer. International Journal of Molecular Sciences, 25, 4548–4577, 2024.

Javier Baena Espinar | Medicine and Dentistry | Best Research Article Award

Dr. Javier Baena Espinar | Medicine and Dentistry | Best Research Article Award 

Medical Oncologist at Hospital 12 de Octubre | Spain

Dr. Javier Baena Espinar is a prominent medical oncology researcher whose work has significantly shaped contemporary understanding of thoracic malignancies, precision oncology, and real-world clinical outcomes. His academic background is grounded in advanced training in health sciences, biomedicine, molecular oncology, immuno-oncology, and cancer biology, supported by multiple postgraduate degrees and specialized certifications that have strengthened his expertise in lung cancer research and evidence-based clinical practice. His professional experience spans leading Spanish healthcare and research institutions, where he has contributed to multidisciplinary oncology teams, national research initiatives, and international collaborative networks focused on improving diagnostic accuracy, treatment personalization, and therapeutic decision-making. His research interests center on non-small cell lung cancer, small cell lung cancer, immune checkpoint inhibitors, next-generation sequencing, biomarker discovery, outcomes research, and the intersection between cancer care and infectious disease vulnerabilities. He has been instrumental in studies evaluating immunotherapy effectiveness, prognostic determinants, molecular profiling, and global registry data, producing findings that support the optimization of treatment strategies and guide clinical standards. With 27 published documents, 884 citations from 800 referencing articles, and an h-index of 11, his scholarly contributions reflect sustained impact and influence across oncology and translational research communities. His work appears in high-impact journals and encompasses both clinical and translational dimensions, bridging innovative scientific methodologies with real-world applicability. Through continuous involvement in international collaborations, multicenter studies, and academic dissemination, he has advanced the understanding of patient outcomes, therapeutic safety, and emerging frontiers in cancer treatment. His research trajectory demonstrates a strong commitment to expanding precision medicine, fostering collaborative research excellence, and improving the clinical management of thoracic cancers. Dr. Javier Baena Espinar’s ongoing contributions highlight his dedication to advancing scientific knowledge, strengthening global oncology evidence, and supporting the evolution of patient-centered cancer care.

Profile: Scopus | Orcid

Featured Publications:

  • Baena Espinar, J. (2025). Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first-line pembrolizumab outside clinical trials: Pembro-real 5Y registry results. Journal for Immunotherapy of Cancer.

  • Baena Espinar, J., et al. (2025). Clinical utility of combined tissue and plasma next-generation sequencing in treatment-naïve advanced NSCLC. JTO Clinical and Research Reports.

  • Baena Espinar, J., et al. (2025). Efficacy and safety of lorlatinib in ALK- and ROS1-rearranged metastatic NSCLC within the compassionate use program in Spain.

  • Baena Espinar, J., et al. (2025). Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in lung cancer patients.

  • Baena Espinar, J., et al. (2025). Safety and efficacy of immune checkpoint therapy in patients with cardiac metastasis: A multicenter international retrospective analysis.

  • Baena Espinar, J., et al. (2025). Unmet needs in maintenance therapy for extensive-stage small cell lung cancer.

  • Baena Espinar, J. (2024). Consolidation osimertinib vs durvalumab vs observation after chemoradiation in unresectable EGFR-mutant NSCLC. Journal of Thoracic Oncology.

  • Baena Espinar, J.(2024). Facts and hopes on cancer immunotherapy for small cell lung cancer. Clinical Cancer Research.

  • Baena Espinar, J.(2024). Real-world data of first-line cemiplimab monotherapy for PD-L1 high NSCLC. Journal of Thoracic Oncology.

  • Baena Espinar, J.(2024). Multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage SCLC. Clinical Cancer Research.

  • Baena Espinar, J.(2024). Targeting KRAS G12C in NSCLC: Current standards and developments. Drugs.

  • Baena Espinar, J.(2023). Future perspectives in second-line therapy for non-oncogene–addicted NSCLC. Cancers.

  • Baena Espinar, J. (2023). Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer. Journal of Clinical Oncology.

  • Baena Espinar, J.(2022). Updated prognostication system for thoracic malignancies with COVID-19: TERAVOLT registry. Journal of Thoracic Oncology.

  • Baena Espinar, J. (2022). COVID-19 outcomes, vaccination status, and cancer-related delays during the Omicron wave: TERAVOLT analysis. JTO Clinical and Research Reports.